Long Term Extension Study in Patients With Primary Hyperoxaluria (PHYOX3)
Long Term Extension Study in Patients With Primary Hyperoxaluria (PHYOX3)
The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC long-term access to DCR-PHXC, and to evaluate the long-term safety and efficacy of DCR-PHXC in patients with PH.
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria
Actual Study Start Date: July 9, 2019
Estimated Primary Completion Date: December 2023
Estimated Study Completion Date: December 2023
Arm:
- Experimental: Open Label
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Expected enrolment | 50 |
| Actual Study start date | 09 July 2019 |
| Estimated Study Completion Date | 01 December 2023 |